Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury

Experimental Neurology

Volumn 261, Issue , 2014, Pages 757-771

  Chan, Julie L ^a   Reeves, Thomas M ^a   Phillips, Linda L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; GELATINASE B; MAP1B PROTEIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; MINOCYCLINE; NERVE CELL ADHESION MOLECULE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; SYNAPSIN I; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL COLLAGENASE;

ADULT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN LEVEL; CELL ACTIVATION; CELL ADHESION; CELL MOTILITY; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOKINE RELEASE; ENTORHINAL CORTEX; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENETIC TRANSCRIPTION; GLIA; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SYNAPTOGENESIS; ANIMAL; BRAIN CORTEX; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HEMISPHERIC DOMINANCE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; PHYSIOLOGY; RECOGNITION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MINOCYCLINE; NEUROGENESIS; NEURONAL PLASTICITY; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); TIME FACTORS;

EID: 84908249389     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.08.015     Document Type: Article

References (122)

1. Baratz R., Tweedie D., Rubovitch V., Luo W., Yoon J.S., Hoffer B.J., Greig N.H., Pick C.G. Tumor necrosis factor-alpha synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J. Neurochem. 2011, 118:1032-1042.
2. Belanger M., Magistretti P.J. The role of astroglia in neuroprotection. Dialogues Clin. Neurosci. 2009, 11:281-295.
3. Borges K., Gearing M., Rittling S., Sorensen E.S., Kotloski R., Denhardt D.T., Dingledine R. Characterization of osteopontin expression and function after status epilepticus. Epilepsia 2008, 1675-85.
4. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., Yong V.W. Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis. Brain (England) 2002, 125:1297-1308.
5. Bye N., Habgood M.D., Callaway J.K., Malakooti N., Potter A., Kossmann T., Morganti-Kossmann M.C. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol. 2007, 204:220-233.
6. Cayabyab F.S., Gowribai K., Walz W. Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity. J. Neurosci. Res. 2013, 91:920-933.
7. Cernak I., Merkle A.C., Koliatsos V.E., Bilik J.M., Luong Q.T., Mahota T.M., Xu L., Slack N., Windle D., Ahmed F.A. The pathobiology of blast injuries and blast-induced neurotrauma as identified using a new experimental model of injury in mice. Neurobiol. Dis. 2011, 41:538-551.
8. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001, 294:1731-1735.
9. Choi J.S., Cha J.H., Park H.J., Chung J.W., Chun M.H., Lee M.Y. Transient expression of osteopontin mRNA and protein in amoeboid microglia in developing rat brain. Exp. Brain Res. 2004, 154:275-280.
10. Choi J.S., Kim H.Y., Cha J.H., Choi J.Y., Lee M.Y. Transient microglial and prolonged astroglial upregulation of osteopontin following transient forebrain ischemia in rats. Brain Res. 2007, 1151:195-202.
11. Correale J., Villa A. The neuroprotective role of inflammation in nervous system injuries. J. Neurol. 2004, 251:1304-1316.
12. Crack P.J., Gould J., Bye N., Ross S., Ali U., Habgood M.D., Morganti-Kossman C., Saunders N.R., Hertzog P.J., Victorian Neurotrauma Research Group The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline. J. Neural Transm. 2009, 116:1-12.
13. Csuka E., Morganti-Kossmann M.C., Lenzlinger P.M., Joller H., Trentz O., Kossman T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: Relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J. Neuroimmunol. 1999, 101:211-221.
14. Cunningham L.A., Wetzel M., Rosenberg G.A. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005, 50:329-339.
15. Dalle Lucca J.J., Chavko M., Dubick M.A., Adeeb S., Falabella M.J., Slack J.L., McCarron R., Li Y. Blast-induced moderate neurotrauma (BINT) elicits early complement activation and tumor necrosis factor alpha (TNFalpha) release in a rat brain. J. Neurol. Sci. 2012, 318:146-154.
16. Degos V., Maze M., Vacas S., Hirsch J., Guo Y., Shen F., Jun K., van Rooijen N., Gressens P., Young W.L., Su H. Bone fracture exacerbates murine ischemic cerebral injury. Anesthesiology 2013, 118:1362-1372.
17. del Zoppo G.J., Frankowski H., Gu Y.-H., Osada T., Kanazawa M., Milner R., Wang X., Hosomi N., Mabuchi T., Koziol J.A. Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation. J. Cerebr. 2012, 32:919-932.
18. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., Kipnis J. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 2010, 207:1067-1080.
19. Dityatev A., Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat. Rev. Neurosci. 2003, 4:456-468.
20. Dityatev A., Schachner M. The extracellular matrix and synapses. Cell Tissue Res. 2006, 326:647-654.
21. Dumur C.I., Ladd A.C., Wright H.V., Penberthy L.T., Wilkinson D.S., Powers C.N., Garrett C.T., DiNardo L.J. Genes involved in radiation therapy response in head and neck cancers. Laryngoscope 2009, 119:91-101.
22. Ellison J.A., Velier J.J., Spera P., Jonak Z.L., Wang X., Barone F.C., Feuerstein G.Z. Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. Stroke 1998, 29:1698-1706. (discussion 1707).
23. Ellison J.A., Barone F.C., Feuerstein G.Z. Matrix remodeling after stroke. De novo expression of matrix proteins and integrin receptors. Ann. N. Y. Acad. Sci. 1999, 890:204-222.
24. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res. 1988, 31:47-59.
25. Ethell I.M., Ethell D.W. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J. Neurosci. Res. 2007, 85:2813-2823.
26. Falo M.C., Fillmore H.L., Reeves T.M., Phillips L.L. Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J. Neurosci. Res. 2006, 84:768-781.
27. Falo M.C., Reeves T.M., Phillips L.L. Agrin expression during synaptogenesis induced by traumatic brain injury. J. Neurotrauma 2008, 25:769-783.
28. Fifre A., Sponne I., Koziel V., Kriem B., Yen Potin F.T., Bihain B.E., Olivier J.L., Oster T., Pillot T. Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3. J. Biol. Chem. 2006, 281:229-240.
29. Fuller B.F., Cortes D.F., Landis M.K., Yohannes H., Griffin H.E., Stafflinger J.E., Bowers M.S., Lewis M.H., Fox M.A., Ottens A.K. Exposure of rats to environmental tobacco smoke during cerebellar development alters behavior and perturbs mitochondrial energetics. Environ. Health Perspect. 2012, 120:1684-1691.
30. Goussev S., Hsu J.-Y., Lin Y., Tjoa T., Maida N., Werb Z., Noble-Haeusslein L.J. Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing. J. Neurosurg. 2003, 99:188-197.
31. Greif K.F., Trenchard H. Neonatal deafferentation prevents normal expression of synaptic vesicle antigens in the developing rat superior cervical ganglion. Synapse 1988, 2:1-6.
32. Griesbach G.S., Sutton R.L., Hovda D.A., Ying Z., Gomez-Pinilla F. Controlled contusion injury alters molecular systems associated with cognitive performance. J. Neurosci. Res. 2009, 87:795-805.
33. Guest P.C., Urday S., Ma D., Stelzhammer V., Harris L.W., Amess B., Pietsch S., Oheim C., Ozanne S.E., Bahn S. Proteomic analysis of the maternal protein restriction rat model for schizophrenia: identification of translational changes in hormonal signaling pathways and glutamate neurotransmission. Proteomics 2012, 12:3580-3589.
34. Hamby M.E., Sofroniew M.V. Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 2010, 7:494-506.
35. Han H.Q., Nichols R.A., Rubin M.R., Bahler M., Greengard P. Induction of formation of presynaptic terminals in neuroblastoma cells by synapsin IIb. Nature 1991, 349:697-700.
36. Han X., Tong J., Zhang J., Farahvar A., Wang E., Yang J., Samadani U., Smith D.H., Huang J.H. Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice. J. Neurotrauma 2011, 28:995-1007.
37. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
38. Hardman R., Evans D.J., Fellows L., Hayes B., Rupniak H.T., Barnes J.C., Higgins G.A. Evidence for recovery of spatial learning following entorhinal cortex lesions in mice. Brain Res. 1997, 758:187-200.
39. Hashimoto M., Koda M., Ino H., Murakami M., Yamazaki M., Moriya H. Upregulation of osteopontin expression in rat spinal cord microglia after traumatic injury. J. Neurotrauma 2003, 20:287-296.
40. Hashimoto M., Sun D., Rittling S.R., Denhardt D.T., Young W. Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J. Neurosci. 2007, 27:3603-3611.
41. Helmy A., Carpenter K.L., Menon D.K., Pickard J.D., Hutchinson P.J. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 2011, 31:658-670.
42. Higo N., Sato A., Yamamoto T., Nishimura Y., Oishi T., Murata Y., Onoe H., Yoshino-Saito K., Tsuboi F., Takahashi M., Isa T., Kojima T. SPP1 is expressed in corticospinal neurons of the macaque sensorimotor cortex. J. Comp. Neurol. 2010, 518(13):2633-2644.
43. Homsi S., Federico F., Croci N., Palmier B., Plotkine M., Marchand-Leroux C., Jafarian-Tehrani M. Minocycline effects on cerebral edema: Relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res. (Netherlands) 2009, 1291:122-132.
44. Hwang S.M., Lopez C.A., Heck D.E., Gardner C.R., Laskin D.L., Laskin J.D., Denhardt D.T. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J. Biol. Chem. 1994, 269:711-715.
45. Iczkiewicz J., Rose S., Jenner P. Osteopontin (eta-1) is present in the rat basal ganglia. Brain Res. Mol. Brain Res. 2004, 132:64-72.
46. Israelsson C., Lewen A., Kylberg A., Usoskin D., Althini S., Lindeberg J., Deng C.X., Fukuda T., Wang Y., Kaartinen V., Mishina Y., Hillered L., Ebendal T. Genetically modified bone morphogenetic protein signaling alters traumatic brain injury-induced gene expression responses in the adult mouse. J. Neurosci. Res. 2006, 84:47-57.
47. John G.R., Lee S.C., Brosnan C.F. Cytokines: powerful regulators of glial cell activation. Neuroscientist 2003, 9:10-22.
48. Ju W.K., Kim K.Y., Cha J.H., Kim I.B., Lee M.Y., Oh S.J., Chung J.W., Chun M.H. Ganglion cells of the rat retina show osteopontin-like immunoreactivity. Brain Res. 2000, 852(1):217-220.
49. Kang W.S., Choi J.S., Shin Y.J., Kim H.Y., Cha J.H., Lee J.Y., Chun M.H., Lee M.Y. Differential regulation of osteopontin receptors, CD44 and the alpha(v) and beta(3) integrin subunits, in the rat hippocampus following transient forebrain ischemia. Brain Res. 2008, 1228:208-216.
50. Keilhoff G., Langnaese K., Wolf G., Fansa H. Inhibiting effect of minocycline on the regeneration of peripheral nerves. Dev. Neurobiol. 2007, 67:1382-1395.
51. Kelso M.L., Scheff N.N., Scheff S.W., Pauly J.R. Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury. Neurosci. Lett. 2011, 488:60-64.
52. Kim H.J., Fillmore H.L., Reeves T.M., Phillips L.L. Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis. Exp. Neurol. 2005, 192:60-72.
53. Kloss C.U., Werner A., Klein M.A., Shen J., Menuz K., Probst J.C., Kreutzberg G.W., Raivich G. Integrin family of cell adhesion molecules in the injured brain: regulation and cellular localization in the normal and regenerating mouse facial motor nucleus. J. Comp. Neurol. 1999, 411:162-178.
54. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 1998, 153:143-151.
55. Kumar A., Stoica B.A., Sabirzhanov B., Burns M.P., Faden A.I., Loane D.J. Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol. Aging 2013, 34:1397-1411.
56. Lee M.Y., Shin S.L., Choi Y.S., Kim E.J., Cha J.H., Chun M.H., Lee S.B., Kim S.Y. Transient upregulation of osteopontin mRNA in hippocampus and striatum following global forebrain ischemia in rats. Neurosci. Lett. 1999, 271:81-84.
57. Liaw L., Birk D.E., Ballas C.B., Whitsitt J.S., Davidson J.M., Hogan B.L. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 1998, 101:1468-1478.
58. Lively S., Schlichter L.C. The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J. Neuroinflammation 2013, 10:75-88.
59. Loesche J., Steward O. Behavioral correlates of denervation and reinnervation of the hippocampal formation of the rat: recovery of alternation performance following unilateral entorhinal cortex lesions. Brain Res. Bull. 1977, 2:31-39.
60. Long P., Samnakay P., Jenner P., Rose S. A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain. Eur. J. Neurosci. 2012, 36:2733-2742.
61. Lucas S.M., Rothwell N.J., Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. (England) 2006, 147(Suppl 1):S232-S240.
62. Lu L., Tonchev A.B., Kaplamadzhiev D.B., Boneva N.B., Mori Y., Sahara S., Ma D., Nakaya M.A., Kikuchi M., Yamashima T. Expression of matrix metalloproteinases in the neurogenic niche of the adult monkey hippocampus after ischemia. Hippocampus 2008, 18:1074-1084.
63. Lund R.D., Lund J.S. Synaptic adjustment after deafferentation of the superior colliculus of the rat. Science 1971, 171:804-807.
64. Machado L.S., Kozak A., Ergul A., Hess D.C., Borlongan C.V., Fagan S.C. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci. 2006, 7:56.
65. Maetzler W., Berg D., Schalamberidze N., Melms A., Schott K., Mueller J.C., Liaw L., Gasser T., Nitsch C. Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol. Dis. 2007, 25:473-482.
66. Maetzler W., Berg D., Schalamberidze N., Melms A., Schott K., Mueller J.C., Liaw L., Gasser T., Nitsch C. Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol. Dis. 2007, 25(3):473-482.
67. Matsukawa N., Yasuhara T., Hara K., Xu L., Maki M., Yu G., Kaneko Y., Ojika K., Hess D.C., Borlongan C.V. Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci. 2009, 10. (126-2202-10-126).
68. Melloni R.H., Apostolides P.J., Hamos J.E., DeGennaro L.J. Dynamics of synapsin I gene expression during the establishment and restoration of functional synapses in the rat hippocampus. Neuroscience 1994, 58:683-703.
69. Meunier J., Villard V., Givalois L., Maurice T. The gamma-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Abeta1-42 seeding and short-term memory deficits in the Abeta25-35 mouse model of Alzheimer's disease. Eur. J. Pharmacol. 2001, 698:193-199.
70. Milner R., Campbell I.L. The integrin family of cell adhesion molecules has multiple functions within the CNS. J. Neurosci. Res. 2002, 69:286-291.
71. Misawa H., Hara M., Tanabe S., Niikura M., Moriwaki Y., Okuda T. Osteopontin is an alpha motor neuron marker in the mouse spinal cord. J. Neurosci. Res. 2012, 732-742.
72. Moon C., Heo S., Ahn M., Kim H., Shin M., Sim K.B., Kim H.M., Shin T. Immunohistochemical study of osteopontin in the spinal cords of rats with clip compression injury. J. Vet. Med. Sci. 2004, 66:1307-1310.
73. Morganti-Kossmann M.C., Rancan M., Stahel P.F., Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 2002, 8:101-105.
74. Morita M., Imai H., Liu Y., Xu X., Sadamatsu M., Nakagami R., Shirakawa T., Nakano K., Kita Y., Yoshida K., Tsunashima K., Kato N. FK506-protective effects against trimethyltin neurotoxicity in rats: hippocampal expression analyses reveal the involvement of periarterial osteopontin. Neuroscience 2008, 153:1135-1145.
75. Nikonenko I., Toni N., Moosmayer M., Shigeri Y., Muller D., Sargent Jonesm L. Integrins are involved in synaptogenesis, cell spreading, and adhesion in the postnatal brain. Brain Res. Dev. Brain Res. 2003, 140:185-194.
76. Park K.P., Rosell A., Foerch C., Xing C., Kim W.J., Lee S., Opdenakker G., Furie K.L., Lo E.H. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke 2009, 40:2836-2842.
77. Park J.M., Shin Y.J., Kim H.L., Cho J.M., Lee M.Y. Sustained expression of osteopontin is closely associated with calcium deposits in the rat hippocampus after transient forebrain ischemia. J. Histochem. Cytochem. 2012, 60(7):550-559.
78. Patarca R., Freeman G.J., Singh R.P., Wei F.Y., Durfee T., Blattner F., Regnier D.C., Kozak C.A., Mock B.A., Morse H.C. Structural and functional studies of the early T lymphocyte activation 1 (eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 1989, 170:145-161.
79. Pellerin L., Magistretti P.J. Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 2004, 10:53-62.
80. Phillips L.L., Lyeth B.G., Hamm R.J., Povlishock J.T. Combined fluid percussion brain injury and entorhinal cortical lesion: a model for assessing the interaction between neuroexcitation and deafferentation. J. Neurotrauma 1994, 11:641-656.
81. Plantman S. Osteopontin is upregulated after mechanical brain injury and stimulates neurite growth from hippocampal neurons through beta1 integrin and CD44. Neuroreport 2012, 23:647-652.
82. Popa-Wagner A., Schroder E., Schmoll H., Walker L.C., Kessler C. Upregulation of MAP1B and MAP2 in the rat brain after middle cerebral artery occlusion: effect of age. J. Cereb. Blood Flow Metab. 1999, 19:425-434.
83. Povlishock J.T., Katz D.I. Update of neuropathology and neurological recovery after traumatic brain injury. J. Head Trauma Rehabil. 2005, 20:76-94.
84. Power C., Henry S., Del Bigio M.R., Larsen P.H., Corbett D., Imai Y., Yong V.W., Peeling J. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 2003, 53:731-742.
85. Reeves T.M., Steward O. Emergence of the capacity for LTP during reinnervation of the dentate gyrus: evidence that abnormally shaped spines can mediate LTP. Exp. Brain Res. 1986, 65:167-175.
86. Rothwell N.J., Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 2000, 23:618-625.
87. Ruoslahti E. Brain extracellular matrix. Glycobiology 1996, 6:489-492.
88. Sanchez Mejia R.O., Ona V.O., Li M., Friedlander R.M. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001, 48:1393-1399. (discussion 1399-401).
89. Sato K., Morimoto K., Suemaru S., Sato T., Yamada N. Increased synapsin I immunoreactivity during long-term potentiation in rat hippocampus. Brain Res. 2000, 872:219-222.
90. Scatena M., Liaw L., Giachelli M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2302-2309.
91. Shin T., Ahn M., Kim H., Moon C., Kang T.Y., Lee J.M., Sim K.B., Hyun J.W. Temporal expression of osteopontin and CD44 in rat brains with experimental cryolesions. Brain Res. 2005, 1041:95-101.
92. Shin Y.J., Kim H.L., Choi J.S., Choi J.Y., Cha J.H., Lee M.Y. Osteopontin: correlation with phagocytosis by brain macrophages in a rat model of stroke. Glia 2011, 59:413-423.
93. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 1994, 14:615-619.
94. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J. Neuroimmunol. 1997, 72:169-177.
95. Siopi E., Llufriu-Daben G., Fanucchi F., Plotkine M., Marchand-Leroux C., Jafarian-Tehrani M. Evaluation of late cognitive impairment and anxiety states following traumatic brain injury in mice: the effect of minocycline. Neurosci. Lett. 2012, 511:110-115.
96. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 2000, 5:400-407.
97. Steward O. Reorganization of neuronal connections following CNS trauma: principles and experimental paradigms. J. Neurotrauma 1989, 6:99-152.
98. Steward O., Loesche J., Horton W.C. Behavioral correlates of denervation and reinnervation of the hippocampal formation of the rat: open field activity and cue utilization following bilateral entorhinal cortex lesions. Brain Res. Bull. 1977, 2:41-48.
99. Su J., Gorse K., Ramirez F., Fox M.A. Collagen XIX is expressed by interneurons and contributes to the formation of hippocampal synapses. J. Comp. Neurol. 2010, 518:229-253.
100. Suzuki H., Ayer R., Sugawara T., Chen W., Sozen T., Hasegawa Y., Kanamaru K., Zhang J.H. Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats. Crit. Care Med. 2010, 38:612-618.
101. Takafuji V., Forgue M., Unsworth E., Goldsmith P., Wang X.W. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 2007, 26:6361-6371.
102. Takeichi M., Abe K. Synaptic contact dynamics controlled by cadherin and catenins. Trends Cell Biol. 2005, 15:216-221.
103. Tambuyze B.R., Casteleyn C., Vergauwen H., Van Cruchten S., Van Ginneken C. Osteopontin alters the functional profile of porcine microglia in vitro. Cell Biol. Int. 2012, 36:1233-1238.
104. Truett G.E., Heeger P., Mynatt R.L., Truett A.A., Walker J.A., Warman M.L. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Bio.Tech. 2000, 29(52):54.
105. Tschesche H., Zolzer V., Triebel S., Bartsch S. The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. Eur. J. Biochem. 2001, 268:1918-1928.
106. van Velthoven C.T., Heijnen C.J., van Bel F., Kavelaars A. Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury. Stroke 2011, 42:2294-2301.
107. Venstrom K.A., Reichardt L.F. Extracellular matrix. 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB J. 1993, 7:996-1003.
108. Verslegers M., Lemmens K., Van Hove I., Moons L. Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Prog. Neurobiol. 2013, 105:60-78.
109. Vitarbo E.A., Chatzipanteli K., Kinoshita K., Truettner J.S., Alonso O.F., Dietrich W.D. Tumor necrosis factor alpha expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery 2004, 55:416-424. (discussion 424-5).
110. von Gertten C., Flores Morales A., Holmin S., Mathiesen T., Nordqvist A.C. Genomic responses in rat cerebral cortex after traumatic brain injury. BMC Neurosci. 2005, 6:69.
111. Wang X., Louden C., Yue T.L., Ellison J.A., Barone F.C., Solleveld H.A., Feuerstein G.Z. Delayed expression of osteopontin after focal stroke in the rat. J. Neurosci. 1998, 18:2075-2083.
112. Warren K.M., Reeves T.M., Phillips L.L. MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury. J. Neurotrauma 2012, 29:1922-1940.
113. Weber G.F., Cantor H. The immunology of eta-1/osteopontin. Cytokine Growth Factor Rev. 1996, 7:241-248.
114. Wu A., Ying Z., Gomez-Pinilla F. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J. Neurotrauma 2011, 28:2113-2122.
115. Wung J.K., Perry G., Kowalski A., Harris P.L., Bishop G.M., Trivedi M.A., Johnson S.C., Smith M.A., Denhardt D.T., Atwood C.S. Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Curr.Alzheimer Res. 2007, 67-72.
116. Yamagata M., Weine J.A., Sanes J.R. Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. Cell 2002, 110:649-660.
117. Yamamoto T., Oishi T., Higo N., Murayama S., Sato A., Takashima I., Sugiyama Y., Nishimura Y., Murata Y., Yoshino-Saito K., Isa T., Kojima T. Differential expression of secreted phosphoprotein 1 in the motor cortex among primate species and during postnatal development and functional recovery. PLoS One 2011, 8(5):e65701.
118. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15769-15774.
119. Yrjanheikki J., Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13496-13500.
120. Zhao C., Fancy S.P., ffrench-Constant C., Franklin R.J. Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiol. Dis. 2008, 31:209-217.
121. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.
122. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J., Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006, 9:268-275.